These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24507808)

  • 81. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
    Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
    Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia.
    Sasaki K; Jabbour E; Cortes J; Kadia T; Garcia-Manero G; Borthakur G; Jain P; Pierce S; Daver N; Takahashi K; O'Brien S; Kantarjian H; Ravandi F
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):616-624. PubMed ID: 27601000
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
    Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
    Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
    Jabbour E; Takahashi K; Wang X; Cornelison AM; Abruzzo L; Kadia T; Borthakur G; Estrov Z; O'Brien S; Mallo M; Wierda W; Pierce S; Wei Y; Sole F; Chen R; Kantarjian H; Garcia-Manero G
    Am J Hematol; 2013 Oct; 88(10):831-7. PubMed ID: 23760779
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Secondary acute myeloid leukemia - a single center experience.
    Szotkowski T; Rohon P; Zapletalova L; Sicova K; Hubacek J; Indrak K
    Neoplasma; 2010; 57(2):170-8. PubMed ID: 20099982
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation.
    Offman J; Opelz G; Doehler B; Cummins D; Halil O; Banner NR; Burke MM; Sullivan D; Macpherson P; Karran P
    Blood; 2004 Aug; 104(3):822-8. PubMed ID: 15090454
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts.
    Chen Z; Wang SA; Goswami M; Tang G; Routbort MJ; Patel KP; Luthra R; Medeiros LJ; Ok CY
    Leuk Res; 2019 Nov; 86():106227. PubMed ID: 31557598
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Epidemiologic outlook of therapy-related myeloid neoplasms and selection of high-risk patients: A Korean nationwide study.
    Ha H; Kim HJ; Park JH; Shin A; Lee KN; Han K; Lee NR; Hong J
    Cancer; 2022 Nov; 128(21):3888-3896. PubMed ID: 36069361
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Therapy-related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype.
    Tariq H; Barnea Slonim L; Coty Fattal Z; Alikhan MB; Segal J; Gurbuxani S; Helenowski IB; Zhang H; Sukhanova M; Lu X; Altman JK; Chen QC; Behdad A
    Br J Haematol; 2022 Jun; 197(6):736-744. PubMed ID: 35304738
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A focused review of hematopoietic neoplasms occurring in the therapy-related setting.
    Zhang L; Wang SA
    Int J Clin Exp Pathol; 2014; 7(7):3512-23. PubMed ID: 25120730
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune disease.
    DiNardo CD; Ogdie A; Hexner EO; Frey NV; Loren AW; Luger SM
    Leuk Lymphoma; 2013 Jun; 54(6):1235-41. PubMed ID: 23216270
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Updates in molecular genetics of therapy-related myeloid neoplasms.
    Cantu MD
    Semin Diagn Pathol; 2023 May; 40(3):182-186. PubMed ID: 37032284
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.
    Ok CY; Hasserjian RP; Fox PS; Stingo F; Zuo Z; Young KH; Patel K; Medeiros LJ; Garcia-Manero G; Wang SA
    Leukemia; 2014 Jan; 28(1):185-9. PubMed ID: 23787392
    [No Abstract]   [Full Text] [Related]  

  • 96. What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.
    Voso MT; Falconi G; Fabiani E
    Blood; 2021 Sep; 138(9):749-757. PubMed ID: 33876223
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Therapy-related myeloid neoplasms with different latencies: a detailed clinicopathologic analysis.
    Liu YC; Illar GM; Al Amri R; Canady BC; Rea B; Yatsenko SA; Geyer JT
    Mod Pathol; 2022 May; 35(5):625-631. PubMed ID: 34873304
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Case report: Therapy-related myeloid neoplasms in three pediatric cases with medulloblastoma.
    Mak LS; Li X; Chan WYK; Leung AWK; Cheuk DKL; Yuen LYP; So JCC; Ha SY; Liu APY
    Front Oncol; 2024; 14():1364199. PubMed ID: 38595820
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant Progression.
    Travaglini S; Marinoni M; Visconte V; Guarnera L
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791019
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical Evaluation.
    Palmieri R; Paterno G; Mallegni F; Frenza F; De Bernardis I; Moretti F; Meddi E; Del Principe MI; Maurillo L; Venditti A; Buccisano F
    Mediterr J Hematol Infect Dis; 2023; 15(1):e2023051. PubMed ID: 37705524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.